COURSE DIRECTOR
Miglena K. Komforti, D.O. and J. Kenneth Schoolmeester II, M.D.

DESCRIPTION
A conference that takes place on the second Friday of every month where pathologists review peer-reviewed articles as well as new research articles for new developments in subdivisions within pathology (example: New development of breast cancer ancillary tests, treatments, and diagnostic criteria to breast cancer).  

TARGET AUDIENCE
This course is intended primarily for Physicians and Resident Fellows.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Apply new advances in the practice of pathology to their daily clinical work.
• Develop a new understanding in the recent technologic, molecular, digital and other developments in pathology.
• Identify new developments and further pathology knowledge.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification - American Board of Pathology (ABPath)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABPath MOC credit.

AOA
The American Osteopathic Association designates this program for a maximum of 1.00 AOA Category 2-A credits.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies: 
None

All relevant financial relationships listed for these individuals have been mitigated.

QUESTIONS?
Contact Nicole Donnelly